DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old
The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of Covaxin (Covid vaccine) in the age group of two to 18-years-old to its manufacturer Bharat Biotech Ltd, Union Health Ministry…